In lung cancer, a statistically significant difference in [18F]FDG uptake was noted between cancers with no mutated tumour suppressors (Rb, P16, P27 and P53) and cancers with alterations which exhibited higher uptake values [38]. This evidence concerns the gene TP53 and neoplasm.